Abivax Sa American Stock Analysis
| ABVX Stock | 125.55 7.54 5.67% |
Abivax SA American is overvalued with Real Value of 97.9 and Target Price of 123.78. The main objective of Abivax SA stock analysis is to determine its intrinsic value, which is an estimate of what Abivax SA American is worth, separate from its market price. There are two main types of Abivax SA's stock analysis: fundamental analysis and technical analysis.
The Abivax SA stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Abivax SA is usually not traded on Juneteenth Holiday, Independence Day, Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day. Abivax Stock trading window is adjusted to America/New York timezone.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Abivax SA American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Abivax Stock Analysis Notes
About 49.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 3.58. Abivax SA American had not issued any dividends in recent years. For more info on Abivax SA American please contact the company at 33 1 53 83 09 63 or go to https://www.abivax.com.Abivax SA American Investment Alerts
| Abivax SA American appears to be risky and price may revert if volatility continues | |
| The company reported the previous year's revenue of 10.79 M. Net Loss for the year was (176.24 M) with profit before overhead, payroll, taxes, and interest of 6.02 M. | |
| Abivax SA generates negative cash flow from operations | |
| Latest headline from benzinga.com: Whats Happening With French Biotech Abivax Stock On Wednesday |
Abivax Largest EPS Surprises
Earnings surprises can significantly impact Abivax SA's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2025-06-02 | 2025-03-31 | -0.76 | -0.95 | -0.19 | 25 | ||
2024-04-02 | 2024-03-31 | -0.6 | -0.7903 | -0.1903 | 31 | ||
2025-03-24 | 2024-12-31 | -1.29 | -0.8143 | 0.4757 | 36 |
Abivax SA Environmental, Social, and Governance (ESG) Scores
Abivax SA's ESG score is a quantitative measure that evaluates Abivax SA's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Abivax SA's operations that may have significant financial implications and affect Abivax SA's stock price as well as guide investors towards more socially responsible investments.
Abivax Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.19 B.Abivax Profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.98) | (1.03) | |
| Return On Capital Employed | (1.65) | (1.73) | |
| Return On Assets | (0.86) | (0.90) | |
| Return On Equity | (4.34) | (4.13) |
Management Efficiency
Abivax SA American has return on total asset (ROA) of (0.5774) % which means that it has lost $0.5774 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.9978) %, meaning that it created substantial loss on money invested by shareholders. Abivax SA's management efficiency ratios could be used to measure how well Abivax SA manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.03 in 2025. Return On Capital Employed is likely to drop to -1.73 in 2025. At this time, Abivax SA's Non Current Assets Total are fairly stable compared to the past year. Other Current Assets is likely to rise to about 11.3 M in 2025, whereas Total Assets are likely to drop slightly above 106.4 M in 2025.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.64 | 0.61 | |
| Tangible Book Value Per Share | 0.25 | 0.26 | |
| Enterprise Value Over EBITDA | (2.26) | (2.38) | |
| Price Book Value Ratio | 10.50 | 7.67 | |
| Enterprise Value Multiple | (2.26) | (2.38) | |
| Price Fair Value | 10.50 | 7.67 | |
| Enterprise Value | 117.2 M | 174.4 M |
The leadership approach at Abivax SA's fosters a culture of excellence and accountability. Our analysis examines how this culture influences financial outcomes and stock valuation.
Technical Drivers
As of the 14th of December 2025, Abivax SA shows the Risk Adjusted Performance of 0.1461, downside deviation of 2.57, and Mean Deviation of 2.44. Abivax SA American technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.Abivax SA American Price Movement Analysis
The output start index for this execution was thirty-five with a total number of output elements of twenty-six. The Mid-point Price over period is an average of Abivax SA American highest and lowest prices attained during the given period.
Abivax SA Outstanding Bonds
Abivax SA issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Abivax SA American uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Abivax bonds can be classified according to their maturity, which is the date when Abivax SA American has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View | |
| Morgan Stanley 3591 Corp BondUS61744YAK47 | View |
Abivax SA Predictive Daily Indicators
Abivax SA intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Abivax SA stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
| Accumulation Distribution | 0.0627 | |||
| Daily Balance Of Power | (0.92) | |||
| Rate Of Daily Change | 0.94 | |||
| Day Median Price | 126.92 | |||
| Day Typical Price | 126.46 | |||
| Market Facilitation Index | 8.21 | |||
| Price Action Indicator | (5.14) | |||
| Period Momentum Indicator | (7.54) |
Abivax SA Corporate Filings
| 14th of November 2025 Other Reports | ViewVerify | |
| 30th of October 2025 Other Reports | ViewVerify | |
6K | 8th of September 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
| 14th of August 2025 Other Reports | ViewVerify | |
| 31st of July 2025 Other Reports | ViewVerify | |
FWP | 24th of July 2025 A written communication used by offering participants to offer securities to the public or to solicit securities transactions. | ViewVerify |
| 23rd of July 2025 Other Reports | ViewVerify | |
6K | 22nd of July 2025 A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges. | ViewVerify |
Abivax SA Forecast Models
Abivax SA's time-series forecasting models are one of many Abivax SA's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Abivax SA's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Abivax Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Abivax SA prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Abivax shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Abivax SA. By using and applying Abivax Stock analysis, traders can create a robust methodology for identifying Abivax entry and exit points for their positions.
| Last Reported | Projected for Next Year | ||
| Pretax Profit Margin | (16.95) | (16.10) | |
| Operating Profit Margin | (17.18) | (16.32) | |
| Net Loss | (16.33) | (15.51) | |
| Gross Profit Margin | 0.88 | 0.92 |
Current Abivax Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Abivax analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Abivax analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
| Target Price | Advice | # of Analysts | |
| 123.78 | Strong Buy | 7 | Odds |
Most Abivax analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Abivax stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Abivax SA American, talking to its executives and customers, or listening to Abivax conference calls.
Abivax Stock Analysis Indicators
Abivax SA American stock analysis indicators help investors evaluate how Abivax SA stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Abivax SA shares will generate the highest return on investment. By understating and applying Abivax SA stock analysis, traders can identify Abivax SA position entry and exit signals to maximize returns.
| Begin Period Cash Flow | 251.9 M | |
| Long Term Debt | 52.2 M | |
| Common Stock Shares Outstanding | 63 M | |
| Total Stockholder Equity | 40.6 M | |
| Total Cashflows From Investing Activities | 15.8 M | |
| Property Plant And Equipment Net | 2.7 M | |
| Cash And Short Term Investments | 144.2 M | |
| Cash | 144.2 M | |
| Accounts Payable | 43.8 M | |
| Net Debt | -46.9 M | |
| 50 Day M A | 90.9643 | |
| Total Current Liabilities | 92.8 M | |
| Other Operating Expenses | 183.8 M | |
| Non Current Assets Total | 34.6 M | |
| Non Currrent Assets Other | 6.7 M | |
| Stock Based Compensation | 20.2 M |
Additional Tools for Abivax Stock Analysis
When running Abivax SA's price analysis, check to measure Abivax SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abivax SA is operating at the current time. Most of Abivax SA's value examination focuses on studying past and present price action to predict the probability of Abivax SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Abivax SA's price. Additionally, you may evaluate how the addition of Abivax SA to your portfolios can decrease your overall portfolio volatility.